Skip to main content
 CHANGE IN VISITATION GUIDELINES: Please read before visiting Rutgers Cancer Institute.

Lung Cancer/Thoracic Oncology Program

The Lung Cancer/Thoracic Oncology Program is a multidisciplinary clinical and scientific group designed to offer a full spectrum of the latest, most advanced treatments for patients with cancer of the lung, pleura and mediastinum.  

The program provides comprehensive and compassionate care to patients through a dedicated team of thoracic surgeons, radiologists, radiation oncologists, medical oncologists, pulmonologists, pathologists, nurses, social workers, nurse navigators, and a nutritionist, who work together to treat patients with cancers originating in the chest and lung (small cell lung cancer and non-small cell lung cancer), mesotheliomas, thyomas and upper esophageal cancers.

Lung Cancer Screening

The Program offers lung cancer screening and surveillance for those who are at high risk for developing the disease due primarily to past or current smoking habits and/or a history of chronic lung disease.  Members of the Lung Cancer/Thoracic Oncology Program participated in the National Lung Cancer Screening Trial (NLST), which showed that screening for lung cancer was more effective with a CT scan of the chest rather than with a chest x-ray. Radiologists of the program were participants in this nationwide study and are available to read a patient's low dose screening chest CT if completed at one of the program's radiology offices.

Customized Treatment

Patients of the Lung Cancer/Thoracic Oncology Program are evaluated for clinical needs and for surgical, radiation therapy and chemotherapy options as well as opportunities for participation in clinical trials. Multimodality treatments are planned together, and approaches for optimal local control and symptom treatments are designed.

The Latest Clinical Trials

As a National Cancer Institute-designated Comprehensive Cancer Center, patients treated at Rutgers Cancer Institute have access to the latest clinical trials and treatment options, some of which are only available at NCI-designated cancer centers.The team is actively involved in developing innovative approaches and participates in national and international clinical trials and works to bring new agents into clinical trials in thoracic cancer.

Click here to view lung cancer clinical trials

Get Help Quitting Tobacco

Rutgers Cancer Institute of New Jersey offers an on-site, nationally-recognized tobacco treatment program through the Tobacco Dependence Program.  The Program's experts meet with individuals to discuss tools available to help them quit and work together to develop an individualized plan to stop smoking.

Members of the Lung Cancer/Thoracic Oncology Program team are experts in the treatment of advanced disease, regionalized disease and the prevention and screening of lung cancer.  


John Langenfeld, MD, Co-Director Lung Cancer / Thoracic Program and Thoracic Surgeon 
Headshot of Missak HaigentzMissak Haigentz, Jr., MD, Chief, Thoracic Medical Oncology; Chief, Head/Neck Medical Oncology

Medical Oncologists

Headshot of Missak HaigentzMissak Haigentz, Jr., MD, Chief, Thoracic Medical Oncology; Chief, Head/Neck Medical Oncology


John Langenfeld, MD, Co-Director Lung Cancer / Thoracic Program and Thoracic Surgeon
Kontopidis headshotIoannis Kontopidis, MDThoracic Surgeon

Radiologist and Radiation Oncologists

Headshot of Dr. DeekMatthew Pierre Deek, MD, Radiation Oncologist
Salma Jabbour, MD, Radiation Oncologist
Judith Amorosa, MD, Radiologist

Pathologists and Pulmonologist

Hua Zhong, MD, Pathologist
Malik Deen, MD, Pathologist
Sabiha Hussain, MD, Pulmonologist


Kristen Lindain, APN, Advanced Practice Nurse
Yolanda Asturias, RN, Registered Nurse
Marjorie Pomerantz, RN, Oncology Nurse Navigator

Support Services

Michael Steinberg, MD, Director, Tobacco Dependence Program
Rosemarie Slirzewski, MSW, LCSW, Social Worker

Research Scientist

Sharon Pine, PhD


Useful Links